235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy

235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy

Bibliographic Details
Main Authors: Joseph Markowitz, Anders Berglund, Saurabh Garg, Eric Welsh, Bin Fang, Yuliana Hernandez, Trevor Rose, Jhanelle Gray, John Koomen, James Mule
Format: Article
Language:English
Published: BMJ Publishing Group 2020-11-01
Series:Journal for ImmunoTherapy of Cancer
id doaj-15d27429e07748538fa6e96c868abedb
record_format Article
spelling doaj-15d27429e07748538fa6e96c868abedb2020-12-11T10:00:56ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.0235235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapyJoseph Markowitz0Anders Berglund1Saurabh Garg2Eric Welsh3Bin Fang4Yuliana Hernandez5Trevor Rose6Jhanelle Gray7John Koomen8James Mule9Aff2 Division of Medical Oncology 406C Starling Loving Hall 320 W 10th Ave 43210 Columbus OH USA Aff10 grid.468198.a0000000098915233H. Lee Moffitt Cancer Center Tampa FL USA H. Lee Moffitt Cancer Center and Research Institute, Tampa, USAH. Lee Moffitt Cancer Center and Research Institute, Tampa, USAH. Lee Moffitt Cancer Center and Research Institute, Tampa, USAH. Lee Moffitt Cancer Center and Research Institute, Tampa, USAH. Lee Moffitt Cancer Center and Research Institute, Tampa, USAH. Lee Moffitt Cancer Center and Research Institute, Tampa, USAH. Lee Moffitt Cancer Center and Research Institute, Tampa, USAH. Lee Moffitt Cancer Center and Research Institute, Tampa, USA
collection DOAJ
language English
format Article
sources DOAJ
author Joseph Markowitz
Anders Berglund
Saurabh Garg
Eric Welsh
Bin Fang
Yuliana Hernandez
Trevor Rose
Jhanelle Gray
John Koomen
James Mule
spellingShingle Joseph Markowitz
Anders Berglund
Saurabh Garg
Eric Welsh
Bin Fang
Yuliana Hernandez
Trevor Rose
Jhanelle Gray
John Koomen
James Mule
235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
Journal for ImmunoTherapy of Cancer
author_facet Joseph Markowitz
Anders Berglund
Saurabh Garg
Eric Welsh
Bin Fang
Yuliana Hernandez
Trevor Rose
Jhanelle Gray
John Koomen
James Mule
author_sort Joseph Markowitz
title 235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
title_short 235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
title_full 235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
title_fullStr 235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
title_full_unstemmed 235 Antigen presentation pathways prime melanoma patients for more durable response to anti–PD-1 checkpoint blockade therapy
title_sort 235 antigen presentation pathways prime melanoma patients for more durable response to anti–pd-1 checkpoint blockade therapy
publisher BMJ Publishing Group
series Journal for ImmunoTherapy of Cancer
issn 2051-1426
publishDate 2020-11-01
work_keys_str_mv AT josephmarkowitz 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT andersberglund 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT saurabhgarg 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT ericwelsh 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT binfang 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT yulianahernandez 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT trevorrose 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT jhanellegray 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT johnkoomen 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
AT jamesmule 235antigenpresentationpathwaysprimemelanomapatientsformoredurableresponsetoantipd1checkpointblockadetherapy
_version_ 1724386638608465920

Similar Items